In order to identify which of the two interacting cells (melanoma or BEC) responded to GM-CSF under these conditions, mCherry-expressing YDFR.CB3 cells, DP.CB2 cells or BEC were treated with rhGM-CSF prior to measuring transendothelial migration. This evidence concerns the gene CSF2 and melanoma.